TrialsgrambetaRCTs are beautiful

PEITHO

2014

Pulmonary Embolism Thrombolysis trial

In 1,006 patients with intermediate-risk pulmonary embolism, tenecteplase reduced haemodynamic decompensation but increased major and intracranial bleeding compared with heparin alone.

Result

Efficacy: Death or haemodynamic decompensation at 7 daysOR 0.44

Below 1 favours tenecteplase, above 1 favours heparin alone.

Event rates
Absolute difference
3.0 points

The absolute difference is derived from the event rates.

Also reported: Intracranial haemorrhage 2.0 % vs 0.2 %.

Original publication
Subtopic
Pulmonary embolism
Design
Double-blind RCT
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Meyer G, et al. N Engl J Med. 2014;370(15):1402-1411.doi 10.1056/NEJMoa1302097

Discussion & critique

Net harm from routine full-dose fibrinolysis in intermediate-risk PE: class III. Drove interest in reduced-dose lysis and catheter-directed therapy.

Discussed in podcasts